Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389(10082):1941–52.

Article  PubMed  Google Scholar 

Neumark N, Cosme C Jr, Rose KA, et al. The idiopathic pulmonary fibrosis cell Atlas. Am J Physiol Lung Cell Mol Physiol. 2020;319(6):L887–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lederer DJ, Martinez FJ. Idiopathic pulmonary fibrosis. N Engl J Med. 2018;378(19):1811–23.

Article  CAS  PubMed  Google Scholar 

Raghu G, Amatto VC, Behr J, Stowasser S. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J. 2015;46(4):1113–30.

Article  CAS  PubMed  Google Scholar 

Oldham JM, Collard HR. Comorbid conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management. Front Med (Lausanne). 2017;4:123.

Article  PubMed  Google Scholar 

Enomoto T, Usuki J, Azuma A, Nakagawa T, Kudoh S. Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis. Chest. 2003;123(6):2007–11.

Article  PubMed  Google Scholar 

Kim YJ, Park JW, Kyung SY, et al. Clinical characteristics of idiopathic pulmonary fibrosis patients with diabetes mellitus: the national survey in Korea from 2003 to 2007. J Korean Med Sci. 2012;27(7):756–60.

Article  PubMed  PubMed Central  Google Scholar 

Liu M, Luo P, Liu L, Wei X, Bai X, Li J, Wu L, Luo M. Immune-mediated inflammatory diseases and leukocyte telomere length: a mendelian randomization study. Front Genet. 2023;14:1129247.

Article  PubMed  PubMed Central  Google Scholar 

Jiang Y, Chen R, Xu S, Ding Y, Zhang M, Bao M, He B, Li S. Endocrine and metabolic factors and the risk of idiopathic pulmonary fibrosis: a mendelian randomization study. Front Endocrinol (Lausanne). 2024;14:1321576.

Article  PubMed  Google Scholar 

Bothwell LE, Podolsky SH. The emergence of the Randomized, Controlled Trial. N Engl J Med. 2016;375(6):501–4.

Article  PubMed  Google Scholar 

Sekula P, Del Greco MF, Pattaro C, Köttgen A. Mendelian randomization as an Approach to assess causality using Observational Data. J Am Soc Nephrol. 2016;27(11):3253–65.

Article  PubMed  PubMed Central  Google Scholar 

Smith GD, Ebrahim S. Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1–22.

Article  PubMed  Google Scholar 

Burgess S, Butterworth A, Malarstig A, Thompson SG. Use of mendelian randomisation to assess potential benefit of clinical intervention. BMJ. 2012;345:e7325.

Article  PubMed  Google Scholar 

Dhindsa RS, Mattsson J, Nag A, et al. Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis. Commun Biol. 2021;4(1):392.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Z, Boehnke M, Wen X, Mukherjee B. Revisiting the genome-wide significance threshold for common variant GWAS. G3 (Bethesda). 2021;11(2):jkaa056.

Article  PubMed  Google Scholar 

Burgess S, Thompson SG, CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in mendelian randomization studies. Int J Epidemiol. 2011;40(3):755–64.

Article  PubMed  Google Scholar 

Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, Davey Smith G, Sterne JA. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012;21(3):223–42.

Article  PubMed  PubMed Central  Google Scholar 

Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–65.

Article  PubMed  PubMed Central  Google Scholar 

Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–14.

Article  PubMed  PubMed Central  Google Scholar 

Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.

Article  PubMed  PubMed Central  Google Scholar 

Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–98.

Article  PubMed  PubMed Central  Google Scholar 

Zhu G, Zhou S, Xu Y, Gao R, Li H, Zhai B, Liu X, He Y, Wang X, Han G, Su W, Wang R. Mendelian randomization study on the causal effects of omega-3 fatty acids on rheumatoid arthritis. Clin Rheumatol. 2022;41(5):1305–12.

Article  PubMed  Google Scholar 

Hemani G, Bowden J, Davey Smith G. Evaluating the potential role of pleiotropy in mendelian randomization studies. Hum Mol Genet. 2018;27(R2):R195–208.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yavorska OO, Burgess S. MendelianRandomization: an R package for performing mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46(6):1734–9.

Article  PubMed  PubMed Central  Google Scholar 

Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaneto H, Katakami N, Kawamori D, Miyatsuka T, Sakamoto K, Matsuoka TA, Matsuhisa M, Yamasaki Y. Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal. 2007;9(3):355–66.

Article  CAS  PubMed  Google Scholar 

Tang R, Zhou Y, Mei S, Xu Q, Feng J, Xing S, Gao Y, Qin S, He Z. Fibrotic extracellular vesicles contribute to mechanical ventilation-induced pulmonary fibrosis development by activating lung fibroblasts via JNK signalling pathway: an experimental study. BMJ Open Respir Res. 2023;10(1):e001753.

Article  PubMed  PubMed Central  Google Scholar 

Jagadapillai R, Rane MJ, Lin X, Roberts AM, Hoyle GW, Cai L, Gozal E. Diabetic Microvascular Disease and Pulmonary Fibrosis: the contribution of platelets and systemic inflammation. Int J Mol Sci. 2016;17(11):1853.

Article  PubMed  PubMed Central  Google Scholar 

Gressner OA, Gressner AM. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int. 2008;28(8):1065–79.

Article  CAS  PubMed  Google Scholar 

Wang CM, Hsu CT, Niu HS, Chang CH, Cheng JT, Shieh JM. Lung damage induced by hyperglycemia in diabetic rats: the role of signal transducer and activator of transcription 3 (STAT3). J Diabetes Complications. 2016 Nov-Dec;30(8):1426–33.

Fariña J, Furió V, Fernandez-Aceñero MJ, Muzas MA. Nodular fibrosis of the lung in diabetes mellitus. Virchows Arch. 1995;427(1):61–3.

Article  PubMed  Google Scholar 

Wolters PJ, Collard HR, Jones KD. Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol. 2014;9:157–79.

Article  CAS  PubMed  Google Scholar